FGF18 and cancer: These findings suggest that Spp1/OPN-mediated cell-cell communication, potentially involving FGF18 signaling, are not restricted to fibrotic liver disease but may represent a broader mechanism of stromal crosstalk across multiple cancer types, including cholangiocarcinoma and prostate cancer.